Keytruda & Bavencio Win EU Nod For More Cancers
The European Medicines Agency has recommended that the therapeutic indications of Keytruda and Bavencio should be expanded again.
The European Medicines Agency has recommended that the therapeutic indications of Keytruda and Bavencio should be expanded again.